Nanomedicine entry into cancer cells can be tuned by modulating the stiffness of the plasma membrane
Nanomedicines need to get taken up by diseased cells in order to release their cargo. Cancer cells have altered membrane properties, which hamper their ability to take up nanomedicines. A research team led by Prof. Dr. Prasad Shastri at the University of Freiburg has shown that, the stiffness of cancer cell plasma membrane affects how nanoparticles get internalized, and this process can be enhanced when the cell plasma membrane stiffness is increased. These findings are published in the scientific journal Small.
“In order to increase therapeutic effectiveness, it is critical to find general principles that can positively influence uptake of nanomedicines into cells” emphasizes Shastri. A cell swallows nanomaterial from its immediate environment via deformation of the cell membrane through a process called endocytosis.
According to Shastri, up to this point research efforts have primarily focused on how and which membrane proteins are responsible for this process. It is still relatively unclear what role the biophysical properties of cell membrane play in this process.
The Freiburg team of Shastri, Dr. Shengnan Xiang and Dr. Melika Sarem, have now discovered that liposomes – nanoscale vesicles of lipid molecules encompassing an aqueous core – can be used to alter the stiffness of the cell plasma membrane through lipid transfer.
Increasing the stiffness of cancer cell membrane enhanced the entry of polymer nanoparticles through pathways rich in cholesterol. “The results show that the biophysical properties of the cell membrane provide important starting points for further improving targeted treatment of tumor cells," summarizes Shastri.
Prasad Shastri is the Professor of Biofunctional Macromolecular Chemistry at the Institute for Macromolecular Chemistry and the Professor of Cell Signalling Environments in the Cluster of Excellence BIOSS Centre for Biological Signalling Studies at the University of Freiburg.
Shengnan Xiang, Melika Sarem, Samveg Shah, and V. Prasad Shastri (2018): Liposomal Treatment of Cancer Cells Modulates Uptake Pathway of Polymeric Nanoparticles by Altering Membrane Stiffness. In: Small. doi: 10.1002/smll.201704245
Prof. Dr. Prasad Shastri
Institute for Macromolecular Chemistry & BIOSS Centre for Biological Signalling Studies
University of Freiburg
Rudolf-Werner Dreier | idw - Informationsdienst Wissenschaft
Molecular doorstop could be key to new tuberculosis drugs
20.03.2018 | Rockefeller University
Modified biomaterials self-assemble on temperature cues
20.03.2018 | Duke University
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
20.03.2018 | Physics and Astronomy
20.03.2018 | Physics and Astronomy
20.03.2018 | Earth Sciences